ARKO DATTA

IPL ecosystem value grows to $11.2 billion in 2023: D&P Advisory

BL Net Mail

GIC close to buying majority stake in ESR India for $400 million

New track needed for Vande Bharat export plan

Editorial. Women’s quota a milestone, but delay is puzzling

Global fiscal indices tell a grim story

Infra needs green ratings

Latest News

2023-09-21T13:55:07+05:30 - Markets EaseMyTrip’s introduces smart voice recognition
2023-09-21T13:53:14+05:30 - Markets M&M shares dip as Resson Aerospace winds up
2023-09-21T13:48:26+05:30 - Technical Analysis US Fed decision and Jerome Powell’s hawkish talk: How it impacted asset classes across the world

State of the Economy

State of the Economy. ‘Need industry-wide solutions for healthcare compliance’

Episode 100: Pharma | Jyothi Datta talks to Dharmil Sheth, co-founder of PharmEasy, about the importance and role of online pharmacies in the healthca

By PT Jyothi Datta Jayapriyanka J Anjana P V

‘Gig work is a job, but not the job’

WITH V Nivedita Jayapriyanka J

By Jayapriyanka J

Indian real estate sector is witnessing a resilient comeback post Covid-19: Ashish Khandelia, Founder, Certus Capital

WITH Abhishek Law Nabodita Ganguly

By Abhishek Law

By Nabodita Ganguly

As Twitter rebrands to X and Air India does an identity rejig, a look at why the right logo matters

WITH Chitra Narayanan V Nivedita

By Chitra Narayanan

Can self-regulation help the FinTech sector?

WITH Jyoti Banthia Anjana P V Nabodita Ganguly

By Jyoti Banthia

By Nabodita Ganguly

Today’s Poll

bl21_ndanm_DMKw+GKK1F5DRS.3.jpg.jpg

Will the Women’s Reservation Bill bring gender equality to the Parliament?

Editor's Pick

‘Picking the right AI technology is only one-third of the battle’

Balaji W S 463@Chennai

Nifty at all-time high, but not on valuations?

Study abroad with a travel cover from home

Treading warily on the health front

Health insurance: Why bonus and restoration benefit may not suffice

Indian data centres: Growth, investments and challenges

Companies

KSL

Cipla’s InvaGen site gets 5 USFDA observations

InvaGen Pharmaceuticals is a wholly-owned subsidiary of Cipla, and the latter’s shares were down over 2 percent on BSE, Thursday, at ₹1,213.25 (at 13.

Nvidia Corp. Chief Executive Officer Jensen Huang with Prime Minister Narendra Modi in New Delhi

Nvidia CEO touts India as major AI market in bid to hedge China risks

Mohak Nahta, Founder of Atlys

Digital visa platform Atlys raises $12 million in Series A round

Govt to offload upto 4.92 per cent in SJVN on Thursday

NoBrokerHood, a visitor, society and payment management app joins the ONDC network

Sign into Unlock benefits!

Access 10 free stories per month
Access to comment on every story
Sign up/Manage to our newsletters
Get notified by email for early preview to new features, discounts & offers